The recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack of understanding of its value.
Yamini Misra
Advertisement
Yamini Misra, MBA is the Vice President, Management Consulting Practice, AESARA Inc.
Articles by Yamini Misra
Advertisement
Latest Updated Articles
HEOR: From Proving Product Value to Proving Its Own WorthPublished: March 6th 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma
2
The Situation We Faced: The Development and Commercialization of MariTide
3
Most Favored Nation Order: Legal Battles, Market Shifts, and the Future of Drug Pricing Reform
4
Novo Nordisk Enters $4.7 Billion Definitive Agreement with Akero Therapeutics
5
